Diabetes Mellitus, Type 2LIVENNCT05630508
Lifestyle Management App for Adults With Diabetes Type
A study testing interactive Mhealth Lifestyle behavior intervention in people with Diabetes Mellitus, Type 2, run by Princess Nourah Bint Abdulrahman University at 1 site in Saudi Arabia.
Trial summary
This study will evaluate whether the 12-week health coaching mobile application (LIVEN) will succeed in enhancing lifestyle behaviors in adults with Type 2 Diabetes compared to typical treatment. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Diabetes Mellitus, Type 2
- What is being tested?
- interactive Mhealth Lifestyle behavior intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 90 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 1 Oct 2022to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults, aged 18 years or older
- Arabic speakers
- Capable of utilizing smartphones
- Diagnosed with T2DM
- Poor glycemic control: A1c > 7.5%
Who cannot join
- Individuals using insulin injection
- Individuals suffering from disorders that might affect intervention (e.g. amputation, enucleation of the eye, or end-stage kidney disease)
- Women who are pregnant or breastfeeding
- Individuals diagnosed with other types of diabetes (such as type I or MODY)
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Saudi Arabia1 site, 1 recruiting
- Recruiting
Princess Nourah bint Abdulrahman University
Riyadh, Riyadh Region, 11321
Shaima A Alothman, PhD, +966503952053, shaalothman@pnu.edu.sa
About this study
Official title: mHealth Lifestyle Management Program (LIVEN) For Adults With Diabetes Type 2: A Feasibility Study
This study will evaluate whether the 12-week health coaching mobile application (LIVEN) will succeed in enhancing lifestyle behaviors in adults with Type 2 Diabetes compared to typical treatment. The mobile application's viability will be assessed in 2 parts; the first part is testing easiness and friendliness of using Liven by the patient and health coach. The second part is evaluating the suitability of Liven education material for the patients and whether the coaching program results in enhancing lifestyle behaviors and blood sugar levels. the investigators hypothesize that the 12-week online lifestyle-coaching program will be viable, and a full-scale study can proceed.
Read the detailed description
This study will investigate the feasibility of a 12-weeks online lifestyle (nutrition and physical behavior) coaching program through a mobile app (LIVEN) compared to standard treatment for people with type 2 diabetes. This study will be done in two phases; the first phase is the usability study (phase1), in which the user friendliness of the application will be assessed, and any technical flaws will be resolved prior and during the second phase. The second phase of the study will consist of adapting a diabetes educational material and assessing the feasibility of the program (phase2). the investigators hypothesize that the 12-week online lifestyle-coaching program will be feasible, and a full-scale study can proceed.
- Conditions
- Diabetes Mellitus, Type 2
- Being tested
- interactive Mhealth Lifestyle behavior intervention, Sham
- Keywords
- Type 2 diabetes management, Mhealth lifestyle management program
- Medical subject headings
- Diabetes Mellitus, Type 2
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
interactive Mhealth Lifestyle behavior interventionBehavioural
Receiving Standard care, LIVEN educational material and interactive LIVEN application, via having a human component which is a health coach for 3 months
ShamOther
Receiving standard care, LIVEN educational material and access to the application
| Study group | Role | What they receive |
|---|---|---|
| interactive mhealth Lifestyle behavior intervention | Experimental | Receiving Standard care, LIVEN educational material and interactive LIVEN application Receives: Behavioral: interactive Mhealth Lifestyle behavior intervention |
| Sham group - app access only | Sham comparator | Receiving standard care, LIVEN educational material and access to the application Receives: Other: Sham |
| Control group - Standard care | No intervention | Receiving Standard care only |
What is being measured
The primary outcome is the main question the study is designed to answer.
recruitment rate - descriptive
reported as the number of participants' consented divide by the number of people that were invited to participate
Measured: immediately after the intervention (3 months)
retention rates
reported as the number of participants completing all study sessions
Measured: immediately after the intervention (3 months)
User friendliness
will be assessed via user engagement tracking in the app
Measured: Daily application engagement data for each patient will be analyzed once at the end of the patient's 12 week program.
Secondary outcomes (7)
Glycemic control - A1c
will be assess via A1c blood test will be reported as percentage. higher % indicate worse outcome
Measured: will be assessed one week prior to the intervention and one week after the end of the intervention
Glycemic control - continuous glucose mentoring (CGM)
will be assess via continuous glucose mentoring (CGM) as variability. higher variability indicates worse outcome
Measured: will be assessed one week prior to the intervention and one week after the end of the intervention
Body composition - fat free mass (%) physiological parameter
will be assessed via Bioelectrical Impedance Analysis (BIA). fat free mass (%) will reported as percentage. higher % indicate better outcome
Measured: will be assessed one week prior to the intervention and one week after the end of the intervention
Lifestyle behaviors - Health-Promoting Lifestyle profile II (Questionnaire)
will be assessed via Health-Promoting Lifestyle profile II. HPLP-II is a 4-point Likert scale with 52 items including six subscales: health responsibility, physical activity, nutrition, spiritual growth, interpersonal relationships, and stress management. scores range from 52 to 208. higher scores indicate better outcome.
Measured: will be assessed one week prior to the intervention and one week after the end of the intervention
physical performance assessments - upper body muscle strength in kg
will be assessed via Hand Grip Strength using dynameter (power in kg), higher scores indicate higher physical performance
Measured: will be assessed one week prior to the intervention and one week after the end of the intervention
physical performance assessments - lower body muscle strength in counts
will be assessed via Sit to Stand Test (count), higher counts indicate higher physical performance
Measured: will be assessed one week prior to the intervention and one week after the end of the intervention
physical performance assessments - endurance
will be assessed via 6-minute walk test (distance in m). higher distance indicates higher endurance
Measured: will be assessed one week prior to the intervention and one week after the end of the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Nov 2022
- Study start1 Oct 2022
- Primary completion1 Sep 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diabetes Mellitus, Type 2Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants are assigned to one of three groups in parallel for the duration of the study
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 90 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Princess Nourah Bint Abdulrahman University
- Sponsor type
- University, hospital or other
- Collaborators
- Liven
- Responsible party
- Principal investigator, Shaima Alothman, Princess Nourah Bint Abdulrahman University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05630508
- Sponsor's protocol ID
- 22-0140
- Acronym
- LIVEN
- Status last verified
- Jun 2025
- First submitted
- 10 Oct 2022
- Last updated
- 26 Jun 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 26 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- mHealth Lifestyle Management Program (LIVEN) For Adults With Diabetes Type 2: A Feasibility Study
- ClinicalTrials.gov ID
- NCT05630508
- Acronym / sponsor ID
- LIVEN / 22-0140
- Conditions
- Diabetes Mellitus, Type 2
- Keywords
- Type 2 diabetes management, Mhealth lifestyle management program
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 90 participants (estimated)
- Lead sponsor
- Princess Nourah Bint Abdulrahman UniversityUniversity, hospital or other
- Collaborators
- Liven
- Study start
- 1 Oct 2022 (actual)
- Primary completion
- 1 Sep 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 29 Nov 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will evaluate whether the 12-week health coaching mobile application (LIVEN) will succeed in enhancing lifestyle behaviors in adults with Type 2 Diabetes compared to typical treatment. The mobile application's viability will be assessed in 2 parts; the first part is testing easiness and friendliness of using Liven by the patient and health coach. The second part is evaluating the suitability of Liven education material for the patients and whether the coaching program results in enhancing lifestyle behaviors and blood sugar levels. the investigators hypothesize that the 12-week online lifestyle-coaching program will be viable, and a full-scale study can proceed.
Detailed description
This study will investigate the feasibility of a 12-weeks online lifestyle (nutrition and physical behavior) coaching program through a mobile app (LIVEN) compared to standard treatment for people with type 2 diabetes. This study will be done in two phases; the first phase is the usability study (phase1), in which the user friendliness of the application will be assessed, and any technical flaws will be resolved prior and during the second phase. The second phase of the study will consist of adapting a diabetes educational material and assessing the feasibility of the program (phase2). the investigators hypothesize that the 12-week online lifestyle-coaching program will be feasible, and a full-scale study can proceed.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
- Model description
- Participants are assigned to one of three groups in parallel for the duration of the study
| Arm | Type | Receives |
|---|---|---|
| interactive mhealth Lifestyle behavior intervention | Experimental | Behavioral: interactive Mhealth Lifestyle behavior interventionReceiving Standard care, LIVEN educational material and interactive LIVEN application |
| Sham group - app access only | Sham comparator | Other: ShamReceiving standard care, LIVEN educational material and access to the application |
| Control group - Standard care | No intervention | –Receiving Standard care only |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Adults, aged 18 years or older
- Arabic speakers
- Capable of utilizing smartphones
- Diagnosed with T2DM
- Poor glycemic control: A1c > 7.5%
Key exclusion criteria (4 listed)
- Individuals using insulin injection
- Individuals suffering from disorders that might affect intervention (e.g. amputation, enucleation of the eye, or end-stage kidney disease)
- Women who are pregnant or breastfeeding
- Individuals diagnosed with other types of diabetes (such as type I or MODY)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| interactive Mhealth Lifestyle behavior interventionReceiving Standard care, LIVEN educational material and interactive LIVEN application, via having a human component which is a health coach for 3 months | Behavioural | interactive mhealth Lifestyle behavior intervention |
| ShamReceiving standard care, LIVEN educational material and access to the application | Other | Sham group - app access only |
Primary outcome
recruitment rate - descriptive
Time frame: immediately after the intervention (3 months)
reported as the number of participants' consented divide by the number of people that were invited to participate
retention rates
Time frame: immediately after the intervention (3 months)
reported as the number of participants completing all study sessions
User friendliness
Time frame: Daily application engagement data for each patient will be analyzed once at the end of the patient's 12 week program.
will be assessed via user engagement tracking in the app
7 secondary outcomes
Glycemic control - A1c
Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention
Glycemic control - continuous glucose mentoring (CGM)
Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention
Body composition - fat free mass (%) physiological parameter
Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention
Lifestyle behaviors - Health-Promoting Lifestyle profile II (Questionnaire)
Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention
physical performance assessments - upper body muscle strength in kg
Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention
physical performance assessments - lower body muscle strength in counts
Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention
physical performance assessments - endurance
Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jun 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Diabetes Mellitus, Type 2
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Not yet recruitingPhase 3
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Obesity, Overweight
Not yet recruiting
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing interactive Mhealth Lifestyle behavior intervention in people with Diabetes Mellitus, Type 2, run by Princess Nourah Bint Abdulrahman University at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Shaima A Alothman, PhD (+966503952053, shaalothman@pnu.edu.sa), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
recruitment rate - descriptive (time frame: immediately after the intervention (3 months)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2025.